Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction - ScienceDirect - Bottomline - don’t hesitate to use MRA even if BP is low https://t.co/wmvADJNqQw
RT @JonathanDavisHF: @MohitHarshMD @AndrewJSauer @gcfmd @SJGreene_md @UCSFIMChiefs @beaverspharmd Great paper pooling 4400 HFrEF pts in RAL…
RT @JonathanDavisHF: @MohitHarshMD @AndrewJSauer @gcfmd @SJGreene_md @UCSFIMChiefs @beaverspharmd Great paper pooling 4400 HFrEF pts in RAL…
RT @JonathanDavisHF: @MohitHarshMD @AndrewJSauer @gcfmd @SJGreene_md @UCSFIMChiefs @beaverspharmd Great paper pooling 4400 HFrEF pts in RAL…
RT @JonathanDavisHF: @MohitHarshMD @AndrewJSauer @gcfmd @SJGreene_md @UCSFIMChiefs @beaverspharmd Great paper pooling 4400 HFrEF pts in RAL…
@MohitHarshMD @AndrewJSauer @gcfmd @SJGreene_md @UCSFIMChiefs @beaverspharmd Great paper pooling 4400 HFrEF pts in RALES (spiro)+EMPHASIS (Eplerenone): BP MRA v placebo differed by merely 2.6 mmHg-statistically significant but obviously not clinically rele
@CharetteRN_CCRP @JJheart_doc Great figure! Hadn’t seen that. Can you send link to paper too? This is the paper from the MRA figure I posted https://t.co/7bVuwwmQ7a
MRA therapy is most often not the cause of hypotension and should not be withheld from #gdmtworks for “soft” BP without symptoms. This is pervasive in medicine but incorrect #teamMRA https://t.co/5QDT3mCVem
@Dr_i_presume @MaxJordan_N It is a great med for htn but really doesn’t lower BP much in those with ⬇️ BP/HF https://t.co/ejNY54IAh5 https://t.co/IwD3ImIB2b
RT @RebekkaAnn: Today’s #HFrEF fact about MRAs: “Mean SBP change from baseline to 6 months was +1.4 ± 18.1 mm Hg in the placebo group and −…
Today’s #HFrEF fact about MRAs: “Mean SBP change from baseline to 6 months was +1.4 ± 18.1 mm Hg in the placebo group and −1.2 ± 17.9 mm Hg in the MRA group.” - don’t count out spironolactone and its early mortality benefit for borderline BPs! https://t.co
Don’t worry about BP with MRAs in HFrEF. Just do it. #gdmtforthewin From @jaccjournals https://t.co/2i44VflLel
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
Truth!!!
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
RT @StephDwyer21: Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em…
Friendly reminder that MRAs are NOT potent anti-hypertensives in the setting of HFrEF. If K and renal fxn permit, hit ‘em with it. https://t.co/Ihm7ndOmx3 @accpcardprn @jaccjournals #GDMTworks #CardioTwitter
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
RT @HanCardiomd: What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://…
What is secret behind this magical action of BB, MRA and SGLT2i with SBP in #HFrEF As do beta blockers in HFrEF https://t.co/p2swqQuKiT As do MRA in HFrEF https://t.co/u4fVU8plh6 Empagliflozin in HFrEF https://t.co/MRLJi0fPHS @mvaduganathan @JavedBut
RT @MarkBelkinMD: Reminds me a little of MRAs - https://t.co/7bVuwwEqYI https://t.co/lsSBbyzQtH
RT @MarkBelkinMD: Reminds me a little of MRAs - https://t.co/7bVuwwEqYI https://t.co/lsSBbyzQtH
Reminds me a little of MRAs - https://t.co/7bVuwwEqYI https://t.co/lsSBbyzQtH
Also keep in mind that spiro has a 2-3 day duration of action, so q48h dosing frequency is not an unreasonable way to break the inertia
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
RT @gcfmd: @DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is…
@DrLuizSilva1 @SJGreene_md @JavedButler1 @scottdsolomon @DrNasrien Thank you The change in SBP with MRA initiation in HFrEF is 1-2 mm Hg if the SBP is low. Neither RALES or EMPHASIS had lower SBP limits. Efficacy and safety in subgroup with SBP <= 105
RT @drpallaviojha: Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction: ht…
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction: https://t.co/PkdM42U0HQ
The article supporting the last tweet on blood pressure and MRA @QCardiology
@shelleyw1023 Here you go: https://t.co/fZKaC93I6U
@hurryknee Join the bandwagon!! Amazing for HF, obviously. Interestingly, in HF patients spiro has little BP effect. https://t.co/BdTiLibQvr
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
RT @HJRyooAli: #ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US v…
#ACCEL podcast: MRAs for HFrEF reviewed by @a_l_bailey, Dr. John McMurray, @noshreza. MRAs were prescribed only 40% in US vs 80% in Europe - perhaps due to fear of hypotension? https://t.co/HdZyDkQAXg shows MRAs benefit pts with ⬇️ SBP! #GDMTWorks 🙏summ
RT @JACCJournals: Did you know: MRAs like spironolactone, have little effect on systolic #bloodpressure (SBP), infrequently caused hypotens…
RT @SABOURETCardio: Reassuring data (if needed) about #MRA under prescribed in #HF with rEF. #CardioTwitter